BR112017006770A2 - composições farmacêuticas e alimentícias para induzir a satisfação e prolongar a saciedade em indivíduos que precisam do mesmo - Google Patents

composições farmacêuticas e alimentícias para induzir a satisfação e prolongar a saciedade em indivíduos que precisam do mesmo

Info

Publication number
BR112017006770A2
BR112017006770A2 BR112017006770-6A BR112017006770A BR112017006770A2 BR 112017006770 A2 BR112017006770 A2 BR 112017006770A2 BR 112017006770 A BR112017006770 A BR 112017006770A BR 112017006770 A2 BR112017006770 A2 BR 112017006770A2
Authority
BR
Brazil
Prior art keywords
satisfaction
need
individuals
induce
pharmaceutical
Prior art date
Application number
BR112017006770-6A
Other languages
English (en)
Portuguese (pt)
Inventor
FETISSOV Serguei
Dechelotte Pierre
BRETON Jonathan
Lambert Gregory
Original Assignee
Inserm (Institut National De La Santé Et De La Recherche Médicale);
Centre Hospitalier Universitaire De Rouen
Université de Rouen
Targedys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm (Institut National De La Santé Et De La Recherche Médicale);, Centre Hospitalier Universitaire De Rouen, Université de Rouen, Targedys filed Critical Inserm (Institut National De La Santé Et De La Recherche Médicale);
Publication of BR112017006770A2 publication Critical patent/BR112017006770A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112017006770-6A 2014-10-02 2015-06-05 composições farmacêuticas e alimentícias para induzir a satisfação e prolongar a saciedade em indivíduos que precisam do mesmo BR112017006770A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14306552.2 2014-10-02
EP14306552 2014-10-02
PCT/IB2015/001126 WO2016059455A1 (en) 2014-10-02 2015-06-05 Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

Publications (1)

Publication Number Publication Date
BR112017006770A2 true BR112017006770A2 (pt) 2018-11-06

Family

ID=51799054

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112017006770-6A BR112017006770A2 (pt) 2014-10-02 2015-06-05 composições farmacêuticas e alimentícias para induzir a satisfação e prolongar a saciedade em indivíduos que precisam do mesmo
BR112017026241-0A BR112017026241A2 (pt) 2014-10-02 2016-04-05 composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112017026241-0A BR112017026241A2 (pt) 2014-10-02 2016-04-05 composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas

Country Status (14)

Country Link
US (3) US20170252399A1 (cg-RX-API-DMAC10.html)
EP (2) EP3200814B1 (cg-RX-API-DMAC10.html)
JP (3) JP6855372B2 (cg-RX-API-DMAC10.html)
KR (3) KR20170066543A (cg-RX-API-DMAC10.html)
CN (2) CN106999545B (cg-RX-API-DMAC10.html)
AU (2) AU2015332168B2 (cg-RX-API-DMAC10.html)
BR (2) BR112017006770A2 (cg-RX-API-DMAC10.html)
CA (1) CA2962907C (cg-RX-API-DMAC10.html)
ES (3) ES2828952T3 (cg-RX-API-DMAC10.html)
IL (1) IL256136B (cg-RX-API-DMAC10.html)
MX (3) MX386374B (cg-RX-API-DMAC10.html)
PT (1) PT3439684T (cg-RX-API-DMAC10.html)
RU (3) RU2717018C2 (cg-RX-API-DMAC10.html)
WO (2) WO2016059455A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729770B2 (en) 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов
EP3384922A1 (en) * 2017-04-03 2018-10-10 Targedys Brassicaceae protein extract and uses thereof
FR3076981B1 (fr) * 2018-01-19 2020-01-31 Zhivko Radev Methode de fabrication de produits alimentaires a base de yaourt
CN108715851B (zh) * 2018-04-28 2023-05-16 中山大学 一种斜带石斑鱼摄食调控相关基因AgRP1及其应用
EP3886882A1 (en) 2018-11-28 2021-10-06 Targedys Hafnia alvei formulations
JP2022510891A (ja) * 2018-11-28 2022-01-28 タージェディズ 無機成分を含むハフニア・アルベイ（Ｈａｆｎｉａ ａｌｖｅｉ）組成物
MY189523A (en) * 2019-05-22 2022-02-16 Mizkan Holdings Co Ltd Solid composition containing insoluble dietary fiber and method for manufacturing the same
KR102973977B1 (ko) * 2021-11-26 2026-06-09 충남대학교산학협력단 알파-멜라노사이트 자극 호르몬의 펩티드 변이체 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003359A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Helicobacter clpb
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
MX2008009726A (es) * 2006-01-27 2009-03-05 Danisco Uso de microorganismos probioticos para el tratamiento y prevencion de la obesidad y trastornos relacionados.
JP2009534034A (ja) * 2006-04-19 2009-09-24 ノヴォ ノルディスク アクティーゼルスカブ 原核微生物におけるｏ−グリコシル化治療用タンパク質の発現
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2053122A1 (en) * 2007-10-23 2009-04-29 Nestec S.A. Stress tolerant bifidobacteria
IN2014DN07752A (cg-RX-API-DMAC10.html) * 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
US10729770B2 (en) * 2013-12-05 2020-08-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
WO2016193829A1 (en) * 2015-06-05 2016-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof.
CN105979957A (zh) * 2013-12-05 2016-09-28 国家医疗保健研究所 细菌通过模拟α-MSH的CLPB蛋白对宿主进食与情绪的影响
PL3076985T3 (pl) * 2013-12-05 2024-12-16 Institut National De La Santé Et De La Recherche Médicale (Inserm) Kompozycja zawierająca probiotyki z nadekspresją białka clpb do zastosowania w leczeniu otyłości
RU2717018C2 (ru) * 2014-10-02 2020-03-17 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Фармацевтические и пищевые композиции для индукции насыщения и продления чувства сытости у нуждающихся в этом субъектов

Also Published As

Publication number Publication date
MX2017004317A (es) 2017-10-04
RU2017110516A3 (cg-RX-API-DMAC10.html) 2018-11-05
MX2017015702A (es) 2018-12-11
RU2717018C2 (ru) 2020-03-17
JP6876627B2 (ja) 2021-06-02
IL256136A (en) 2018-02-28
RU2017142932A (ru) 2019-07-11
WO2017174658A1 (en) 2017-10-12
EP3769777B9 (en) 2022-10-26
MX386374B (es) 2025-03-18
EP3769777A1 (en) 2021-01-27
CA3020050A1 (en) 2017-10-12
MX2018012056A (es) 2019-03-28
JP2019513832A (ja) 2019-05-30
AU2015332168B2 (en) 2021-02-25
RU2017110516A (ru) 2018-11-05
US11389489B2 (en) 2022-07-19
RU2018138995A3 (cg-RX-API-DMAC10.html) 2020-11-09
US10888592B2 (en) 2021-01-12
IL256136B (en) 2021-02-28
RU2766585C2 (ru) 2022-03-15
EP3200814A1 (en) 2017-08-09
RU2018138995A (ru) 2020-05-12
ES2928379T3 (es) 2022-11-17
JP2018521982A (ja) 2018-08-09
EP3769777B1 (en) 2022-07-27
AU2016272850A1 (en) 2017-12-21
CN106999545A (zh) 2017-08-01
KR20170066543A (ko) 2017-06-14
US20170252399A1 (en) 2017-09-07
AU2015332168A1 (en) 2017-04-20
ES2808939T3 (es) 2021-03-02
ES2828952T3 (es) 2021-05-28
KR102472169B1 (ko) 2022-11-29
WO2016059455A1 (en) 2016-04-21
US20200297783A1 (en) 2020-09-24
HK1252744A1 (zh) 2019-05-31
CN106999545B (zh) 2021-09-21
JP6855372B2 (ja) 2021-04-07
JP2018503597A (ja) 2018-02-08
RU2017142932A3 (cg-RX-API-DMAC10.html) 2019-07-17
PT3439684T (pt) 2020-07-31
KR20180011841A (ko) 2018-02-02
CN109310736B (zh) 2022-09-13
US20190142876A1 (en) 2019-05-16
KR20190010543A (ko) 2019-01-30
BR112017026241A2 (pt) 2018-09-11
CA2962907C (en) 2022-06-07
JP6987122B2 (ja) 2022-01-05
CA2962907A1 (en) 2016-04-21
CN109310736A (zh) 2019-02-05
EP3200814B1 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
DK3559022T3 (da) Virulenssvækket bakteriebaseret proteinlevering
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
ITUB20153066A1 (it) Composizione alimentare e/o nutraceutica contenente pea
MY182667A (en) Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alphalactalbumin protein
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
BR112016018085A2 (pt) composições sinérgicas de suplemento dietético para prevenção, tratamento ou controle de doenças inflamatórias e respectivo método de aplicação das composições sinérgicas
DK3240436T3 (da) Sammensætning indeholdende kitin og fordøjelige proteiner
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
EP3379946C0 (en) FOOD SUPPLEMENT AND COMPOSITION FOR THE TREATMENT OF METABOLIC SYNDROME
EP3189849A4 (en) Novel peptide for inhibiting fat accumulation, and pharmaceutical composition for preventing or treating obesity, comprising same
IL265831A (en) Preparations and methods for protein expression and administration
MA40427A (fr) Composition comprenant des substances naturelles et/ou des extraits
PL3348273T3 (pl) Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
PL3102212T3 (pl) Inhibitor białka przenoszącego estry cholesterolu (CETP) i kompozycje farmaceutyczne zawierające taki inhibitor do stosowania w leczeniu chorób sercowo-naczyniowych lub zapobieganiu im.
BR112016014617A2 (pt) Variante do fator xa (fxa) e usos da referida variante
EP3216456A4 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
BR112017005993A2 (pt) derivados de peptídeo inovadores e usos dos mesmos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.